These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12079499)

  • 1. Functional group interactions of a 5-HT3R antagonist.
    Venkataraman P; Joshi P; Venkatachalan SP; Muthalagi M; Parihar HS; Kirschbaum KS; Schulte MK
    BMC Biochem; 2002 Jun; 3():16. PubMed ID: 12079499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of critical residues in loop E in the 5-HT3ASR binding site.
    Venkataraman P; Venkatachalan SP; Joshi PR; Muthalagi M; Schulte MK
    BMC Biochem; 2002 Jun; 3():15. PubMed ID: 12079500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-HT(3)R binding of lerisetron: an interdisciplinary approach to drug-Receptor interactions.
    Parihar HS; Suryanarayanan A; Ma C; Joshi P; Venkataraman P; Schulte MK; Kirschbaum KS
    Bioorg Med Chem Lett; 2001 Aug; 11(16):2133-6. PubMed ID: 11514154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum protein binding of lerisetron, a novel specific 5HT3 antagonist, in patients with cancer.
    Calvo R; Jiménez RM; Trocóniz IF; Suárez E; Gonzalo A; Lucero ML; Raczka E; Orjales A
    Cancer Chemother Pharmacol; 1998; 42(5):418-22. PubMed ID: 9771958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of lerisetron, a new 5-HT3 receptor antagonist, on ipecacuanha-induced emesis in healthy volunteers.
    Cooper M; Sologuren A; Valiente R; Smith J
    Arzneimittelforschung; 2002; 52(9):689-94. PubMed ID: 12404884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New 2-piperazinylbenzimidazole derivatives as 5-HT3 antagonists. Synthesis and pharmacological evaluation.
    Orjales A; Mosquera R; Labeaga L; Rodes R
    J Med Chem; 1997 Feb; 40(4):586-93. PubMed ID: 9046349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the ligand-binding site of the serotonin 5-HT3 receptor: the role of glutamate residues 97, 224, AND 235.
    Schreiter C; Hovius R; Costioli M; Pick H; Kellenberger S; Schild L; Vogel H
    J Biol Chem; 2003 Jun; 278(25):22709-16. PubMed ID: 12660235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the ligand binding site of the 5-HT3 receptor using site directed mutagenesis: importance of glutamate 106.
    Boess FG; Steward LJ; Steele JA; Liu D; Reid J; Glencorse TA; Martin IL
    Neuropharmacology; 1997; 36(4-5):637-47. PubMed ID: 9225289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacological effect of lerisetron, a new 5-HT3 antagonist, in rats.
    Jauregizar N; Calvo R; Suarez E; Quintana A; Raczka E; Lukas JC
    J Pharm Sci; 2002 Jan; 91(1):41-52. PubMed ID: 11782896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered disposition and effect of lerisetron in rats with elevated alpha 1-acid glycoprotein levels.
    Jauregizar N; Calvo R; Suarez E; Quintana A; Raczka E; Lukas JC
    Pharm Res; 2001 Jun; 18(6):838-45. PubMed ID: 11474789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic-pharmacodynamic modeling of the hydroxy lerisetron metabolite L6-OH in rats: an integrated parent-metabolite model.
    Ortega F; Quintana A; Suárez E; Lukas JC; Jauregizar N; de la Fuente L; Lucero ML; Gonzalo A; Orjales A; Calvo R
    Pharm Res; 2005 Nov; 22(11):1769-82. PubMed ID: 16158214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 2. Molecular basis of the intrinsic efficacy of arylpiperazine derivatives at the central 5-HT3 receptors.
    Cappelli A; Anzini M; Vomero S; Canullo L; Mennuni L; Makovec F; Doucet E; Hamon M; Menziani MC; De Benedetti PG; Bruni G; Romeo MR; Giorgi G; Donati A
    J Med Chem; 1999 May; 42(9):1556-75. PubMed ID: 10229626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site-directed mutagenesis of the serotonin 5-hydroxytrypamine2 receptor: identification of amino acids necessary for ligand binding and receptor activation.
    Wang CD; Gallaher TK; Shih JC
    Mol Pharmacol; 1993 Jun; 43(6):931-40. PubMed ID: 8316224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in the central nervous system distribution and pharmacology of the mouse 5-hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modeling.
    Hirst WD; Abrahamsen B; Blaney FE; Calver AR; Aloj L; Price GW; Medhurst AD
    Mol Pharmacol; 2003 Dec; 64(6):1295-308. PubMed ID: 14645659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2,3-Dihydro-2-oxo-1H-benzimidazole-1-carboxamides with selective affinity for the 5-HT(4) receptor: synthesis and structure-affinity and structure-activity relationships of a new series of partial agonist and antagonist derivatives.
    Tapia I; Alonso-Cires L; López-Tudanca PL; Mosquera R; Labeaga L; Innerárity A; Orjales A
    J Med Chem; 1999 Jul; 42(15):2870-80. PubMed ID: 10425096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of tryptophan residues in the 5-Hydroxytryptamine(3) receptor ligand binding domain.
    Spier AD; Lummis SC
    J Biol Chem; 2000 Feb; 275(8):5620-5. PubMed ID: 10681544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative receptor mapping of serotoninergic 5-HT3 and 5-HT4 binding sites.
    López-Rodríguez ML; Morcillo MJ; Benhamú B; Rosado ML
    J Comput Aided Mol Des; 1997 Nov; 11(6):589-99. PubMed ID: 9491351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of 4 radiolabeled antagonists for serotonin 5-HT(7) receptor neuroimaging: toward the first PET radiotracer.
    Lemoine L; Andries J; Le Bars D; Billard T; Zimmer L
    J Nucl Med; 2011 Nov; 52(11):1811-8. PubMed ID: 21990574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunolabelling of the rat intestinal tract with antibodies specific to the long form of the 5-hydroxytryptamine3 receptor.
    Doucet E; Hamon M; Emerit MB
    Neuroscience; 1998 Dec; 87(3):691-707. PubMed ID: 9758234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of [3H]YM060 binding to native and cloned rat 5-HT3 receptors.
    Akuzawa S; Miyake A; Miyata K; Fukutomi H
    Eur J Pharmacol; 1996 Jan; 296(2):227-30. PubMed ID: 8838461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.